Contents

Current Pharmaceutical Design, Volume 16 - Number 5

Editorial [Hot topic: New Strategies in the Search of Antipsychotic Drugs (Executive Editor: Albert Adell)]

, 16(5): 486 - 487

Albert Adell


DOI: 10.2174/138161210790361443




Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?

, 16(5): 488 - 501

Richard B. Mailman and Vishakantha Murthy


DOI: 10.2174/138161210790361461




Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex

, 16(5): 502 - 515

Xavier Lopez-Gil, Francesc Artigas and Albert Adell


DOI: 10.2174/138161210790361416




Antipsychotic Medication: The Potential Role of 5-HT1A Receptor Agonism

, 16(5): 516 - 521

Andrew C. McCreary and Caitlin A. Jones


DOI: 10.2174/138161210790361470




Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis

, 16(5): 522 - 537

Guochuan E. Tsai and Pao-Yen Lin


DOI: 10.2174/138161210790361452




Targeting α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia

, 16(5): 538 - 554

Mihaly Hajos and Bruce N. Rogers


DOI: 10.2174/138161210790361434




Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?

, 16(5): 555 - 566

Rudolf L. Then and Hans-Georg Sahl


DOI: 10.2174/138161210790361407




The Synergistic Use of Computation, Chemistry and Biology to Discover Novel Peptide-Based Drugs: The Time is Right

, 16(5): 567 - 582

J. Audie and C. Boyd


DOI: 10.2174/138161210790361425




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science